VEGFA and cancer: Hence, anti‐angiogenic therapy that blocks pro‐angiogenesis signallings such as vascular endothelial growth factor (VEGF)/ VEGF receptor (VEGFR) signalling pathway, is becoming a vital therapeutic option in various cancer types (Figure 4).